View More Recent Stories
-
William Blair Starts Tempus AI Inc (TEM) at Outperform
-
Needham Starts Tempus AI Inc (TEM) at Buy
-
TD Cowen Starts Tempus AI Inc (TEM) at Buy, 'largest oncology Dx co.'
-
Morgan Stanley Starts Tempus AI Inc (TEM) at Overweight
-
JPMorgan Starts Tempus AI Inc (TEM) at Overweight
-
Stifel Starts Tempus AI Inc (TEM) at Buy
-
Tempus AI (TEM) Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF
-
Tempus AI (TEM) Prices 11.1M Share IPO at $37/sh
-
Tempus AI (TEM) IPO Opens Higher by 8%
-
Tempus AI (TEM) Indicated At $47, IPO Priced At $37

